Abbott’s Vancomycin “Spread” Is Target Of DoJ Suit
This article was originally published in The Pink Sheet Daily
Ven-A-Care suit, taken up by Department of Justice, alleges Medicare and Medicaid paid an excess of $75 mil. for the antibiotic.
You may also be interested in...
Under a settlement with the Justice Department, GlaxoSmithKline will pay $150 mil. and expand compliance program training required by an existing corporate integrity agreement.
Adiana uses a polymer matrix insert to block the fallopian tubes instead of a metal coil, offering a benefit over Essure, which carries a perforation risk on implantation, Hologic exec says.
The results show that cardiac resynchronization defibrillators "slow the progression of heart failure in asymptomatic and mildly symptomatic patients," potentially expanding the market by $600 million.